🇺🇸 GSK plcGLAXF

Company Update Form 6-K 19-10-2026 13:06:46 EDT

Subject: 6-K — Foreign issuer report

Overview: FDA granted accelerated approval for Jemperli (dostarlimab) to treat adults with MSI-H/dMMR locally advanced rectal cancer based on AZUR-1 trial data.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest